In committee released position papers on the following policy issues: → Clinical trial transparency → Combating counterfeit medicines → Timely access to Gx medicines → Incentives for continued innovation We lobby government agencies and provide advice to legislators and policymakers on issues that impact our business, patients, customers and the wider healthcare industry.